<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37313412</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>21</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>30</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Neuro-PASC is characterized by enhanced CD4+ and diminished CD8+ T cell responses to SARS-CoV-2 Nucleocapsid protein.</ArticleTitle><Pagination><StartPage>1155770</StartPage><MedlinePgn>1155770</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1155770</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2023.1155770</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Many people with long COVID symptoms suffer from debilitating neurologic post-acute sequelae of SARS-CoV-2 infection (Neuro-PASC). Although symptoms of Neuro-PASC are widely documented, it is still unclear whether PASC symptoms impact virus-specific immune responses. Therefore, we examined T cell and antibody responses to SARS-CoV-2 Nucleocapsid protein to identify activation signatures distinguishing Neuro-PASC patients from healthy COVID convalescents.</AbstractText><AbstractText Label="RESULTS">We report that Neuro-PASC patients exhibit distinct immunological signatures composed of elevated CD4<sup>+</sup> T cell responses and diminished CD8<sup>+</sup> memory T cell activation toward the C-terminal region of SARS-CoV-2 Nucleocapsid protein when examined both functionally and using TCR sequencing. CD8<sup>+</sup> T cell production of IL-6 correlated with increased plasma IL-6 levels as well as heightened severity of neurologic symptoms, including pain. Elevated plasma immunoregulatory and reduced pro-inflammatory and antiviral response signatures were evident in Neuro-PASC patients compared with COVID convalescent controls without lasting symptoms, correlating with worse neurocognitive dysfunction.</AbstractText><AbstractText Label="DISCUSSION">We conclude that these data provide new insight into the impact of virus-specific cellular immunity on the pathogenesis of long COVID and pave the way for the rational design of predictive biomarkers and therapeutic interventions.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Visvabharathy, Hanson, Orban, Lim, Palacio, Jimenez, Clark, Graham, Liotta, Tachas, Penaloza-MacMaster and Koralnik.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Visvabharathy</LastName><ForeName>Lavanya</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Ken and Ruth Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hanson</LastName><ForeName>Barbara A</ForeName><Initials>BA</Initials><AffiliationInfo><Affiliation>Ken and Ruth Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Orban</LastName><ForeName>Zachary S</ForeName><Initials>ZS</Initials><AffiliationInfo><Affiliation>Ken and Ruth Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lim</LastName><ForeName>Patrick H</ForeName><Initials>PH</Initials><AffiliationInfo><Affiliation>Ken and Ruth Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palacio</LastName><ForeName>Nicole M</ForeName><Initials>NM</Initials><AffiliationInfo><Affiliation>Department of Microbiology-Immunology, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jimenez</LastName><ForeName>Millenia</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Ken and Ruth Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clark</LastName><ForeName>Jeffrey R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Ken and Ruth Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Graham</LastName><ForeName>Edith L</ForeName><Initials>EL</Initials><AffiliationInfo><Affiliation>Ken and Ruth Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liotta</LastName><ForeName>Eric M</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>Ken and Ruth Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tachas</LastName><ForeName>George</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Drug Discovery &amp; Patents, Antisense Therapeutics Ltd., Melbourne, VIC, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Penaloza-MacMaster</LastName><ForeName>Pablo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Microbiology-Immunology, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koralnik</LastName><ForeName>Igor J</ForeName><Initials>IJ</Initials><AffiliationInfo><Affiliation>Ken and Ruth Davee Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K23 AG078705</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>DP2 DA051912</GrantID><Acronym>DA</Acronym><Agency>NIDA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 EB027049</GrantID><Acronym>EB</Acronym><Agency>NIBIB NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 AR007611</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001422</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 CA060553</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015850">Interleukin-6</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000705834">nucleocapsid phosphoprotein, SARS-CoV-2</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Front Immunol. 2023 Aug 24;14:1275925. doi: 10.3389/fimmu.2023.1275925</RefSource><PMID Version="1">37691950</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015496" MajorTopicYN="Y">CD4-Positive T-Lymphocytes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018414" MajorTopicYN="Y">CD8-Positive T-Lymphocytes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015850" MajorTopicYN="N">Interleukin-6</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19 immunity</Keyword><Keyword MajorTopicYN="N">IL-6</Keyword><Keyword MajorTopicYN="N">T cell memory</Keyword><Keyword MajorTopicYN="N">immunoregulation</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">neuro-PASC</Keyword><Keyword MajorTopicYN="N">proteomics</Keyword></KeywordList><CoiStatement>Author GT was employed by Antisense Therapeutics, Ltd. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>15</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>14</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>14</Day><Hour>3</Hour><Minute>57</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37313412</ArticleId><ArticleId IdType="pmc">PMC10258318</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2023.1155770</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>
W.H. Organization . WHO coronavirus (COVID-19) dashboard, world health organization. World Health Organization Website;  (2023). Available at: https://covid19.who.int/.</Citation></Reference><Reference><Citation>Bowe B, Xie Y, Al-Aly Z. Acute and postacute sequelae associated with SARS-CoV-2 reinfection. Nat Med (2022) 28(11):2398&#x2013;405. doi: 10.1038/s41591-022-02051-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02051-3</ArticleId><ArticleId IdType="pmc">PMC9671810</ArticleId><ArticleId IdType="pubmed">36357676</ArticleId></ArticleIdList></Reference><Reference><Citation>Wanga V, Chevinsky JR, Dimitrov LV, Gerdes ME, Whitfield GP, Bonacci RA, et al. . Long-term symptoms among adults tested for SARS-CoV-2 - united states, January 2020-April 2021. MMWR Morb Mortal Wkly Rep (2021) 70:1235&#x2013;41. doi: 10.15585/mmwr.mm7036a1</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7036a1</ArticleId><ArticleId IdType="pmc">PMC8437054</ArticleId><ArticleId IdType="pubmed">34499626</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. Global prevalence of post-coronavirus disease 2019 (COVID-19) condition or long COVID: a meta-analysis and systematic review. J Infect Dis (2022) 226:1593&#x2013;607. doi: 10.1093/infdis/jiac136</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladds E, Rushforth A, Wieringa S, Taylor S, Rayner C, Husain L, et al. . Persistent symptoms after covid-19: qualitative study of 114 "long covid" patients and draft quality principles for services. BMC Health Serv Res (2020) 20:1144. doi: 10.1186/s12913-020-06001-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-020-06001-y</ArticleId><ArticleId IdType="pmc">PMC7750006</ArticleId><ArticleId IdType="pubmed">33342437</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV, W.H.O.C.C.D.W.G.o.P.-C.-. Condition . A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis (2022) 22:e102&#x2013;7. doi: 10.1016/S1473-3099(21)00703-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Moghimi N, Di Napoli M, Biller J, Siegler JE, Shekhar R, McCullough LD, et al. . The neurological manifestations of post-acute sequelae of SARS-CoV-2 infection. Curr Neurol Neurosci Rep (2021) 21:44. doi: 10.1007/s11910-021-01130-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11910-021-01130-1</ArticleId><ArticleId IdType="pmc">PMC8237541</ArticleId><ArticleId IdType="pubmed">34181102</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. . Post-acute COVID-19 syndrome. Nat Med (2021) 27:601&#x2013;15. doi: 10.1038/s41591-021-01283-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham EL, Clark JR, Orban ZS, Lim PH, Szymanski AL, Taylor C, et al. . Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized covid-19 "long haulers". Ann Clin Transl Neurol (2021) 8:1073&#x2013;85. doi: 10.1002/acn3.51350</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51350</ArticleId><ArticleId IdType="pmc">PMC8108421</ArticleId><ArticleId IdType="pubmed">33755344</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen MS, Kristiansen MF, Hanusson KD, Danielsen ME, S BA, Gaini S, et al. . Long COVID in the faroe islands - a longitudinal study among non-hospitalized patients. Clin Infect Dis (2020) 73(11):e4058&#x2013;63. doi: 10.1093/cid/ciaa1792</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1792</ArticleId><ArticleId IdType="pmc">PMC7799340</ArticleId><ArticleId IdType="pubmed">33252665</ArticleId></ArticleIdList></Reference><Reference><Citation>Shanley JE, Valenciano AF, Timmons G, Miner AE, Kakarla V, Rempe T, et al. . Longitudinal evaluation of neurologic-post acute sequelae SARS-CoV-2 infection symptoms. Ann Clin Transl Neurol (2022) 9:995&#x2013;1010. doi: 10.1002/acn3.51578</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51578</ArticleId><ArticleId IdType="pmc">PMC9268882</ArticleId><ArticleId IdType="pubmed">35702954</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan YQ, Xia MH, Ren L, Zhang YF, Ao QL, Xu SP, et al. . Deficiency of tfh cells and germinal center in deceased COVID-19 patients. Curr Med Sci (2020) 40:618&#x2013;24. doi: 10.1007/s11596-020-2225-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11596-020-2225-x</ArticleId><ArticleId IdType="pmc">PMC7412778</ArticleId><ArticleId IdType="pubmed">32767259</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Zaslavsky M, Su Y, Guo J, Sikora MJ, van Unen V, et al. . KIR(+)CD8(+) T cells suppress pathogenic T cells and are active in autoimmune diseases and COVID-19. Science (2022) 376:eabi9591. doi: 10.1126/science.abi9591</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abi9591</ArticleId><ArticleId IdType="pmc">PMC8995031</ArticleId><ArticleId IdType="pubmed">35258337</ArticleId></ArticleIdList></Reference><Reference><Citation>Toor SM, Saleh R, Sasidharan Nair V, Taha RZ, Elkord E. T-Cell responses and therapies against SARS-CoV-2 infection. Immunology (2021) 162:30&#x2013;43. doi: 10.1111/imm.13262</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imm.13262</ArticleId><ArticleId IdType="pmc">PMC7730020</ArticleId><ArticleId IdType="pubmed">32935333</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathew D, Giles JR, Baxter AE, Oldridge DA, Greenplate AR, Wu JE, et al. . Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications. Science (2020) 369(6508):eabc8511. doi: 10.1126/science.abc8511</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc8511</ArticleId><ArticleId IdType="pmc">PMC7402624</ArticleId><ArticleId IdType="pubmed">32669297</ArticleId></ArticleIdList></Reference><Reference><Citation>McMahan K, Yu J, Mercado NB, Loos C, Tostanoski LH, Chandrashekar A, et al. . Correlates of protection against SARS-CoV-2 in rhesus macaques. Nature (2021) 590:630&#x2013;4. doi: 10.1038/s41586-020-03041-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-03041-6</ArticleId><ArticleId IdType="pmc">PMC7906955</ArticleId><ArticleId IdType="pubmed">33276369</ArticleId></ArticleIdList></Reference><Reference><Citation>Etter MM, Martins TA, Kulsvehagen L, Possnecker E, Duchemin W, Hogan S, et al. . Severe neuro-COVID is associated with peripheral immune signatures, autoimmunity and neurodegeneration: a prospective cross-sectional study. Nat Commun (2022) 13:6777. doi: 10.1038/s41467-022-34068-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-34068-0</ArticleId><ArticleId IdType="pmc">PMC9645766</ArticleId><ArticleId IdType="pubmed">36351919</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanevich OV, Alekseeva EI, Sergeeva M, Fadeev AV, Komissarova KS, Ivanova AA, et al. . SARS-CoV-2 escape from cytotoxic T cells during long-term COVID-19. Nat Commun (2023) 14:149. doi: 10.1038/s41467-022-34033-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-34033-x</ArticleId><ArticleId IdType="pmc">PMC9831376</ArticleId><ArticleId IdType="pubmed">36627290</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Castaneda A, Lu P, Geraghty AC, Song E, Lee MH, Wood J, et al. . Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation. Cell (2022) 185:2452&#x2013;2468 e16. doi: 10.1016/j.cell.2022.06.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.06.008</ArticleId><ArticleId IdType="pmc">PMC9189143</ArticleId><ArticleId IdType="pubmed">35768006</ArticleId></ArticleIdList></Reference><Reference><Citation>Weintraub S, Dikmen SS, Heaton RK, Tulsky DS, Zelazo PD, Bauer PJ, et al. . Cognition assessment using the NIH toolbox. Neurology (2013) 80:S54&#x2013;64. doi: 10.1212/WNL.0b013e3182872ded</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3182872ded</ArticleId><ArticleId IdType="pmc">PMC3662346</ArticleId><ArticleId IdType="pubmed">23479546</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinberg A, Song LY, Wilkening C, Sevin A, Blais B, Louzao R, et al. . Optimization and limitations of use of cryopreserved peripheral blood mononuclear cells for functional and phenotypic T-cell characterization. Clin Vaccine Immunol (2009) 16:1176&#x2013;86. doi: 10.1128/CVI.00342-08</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CVI.00342-08</ArticleId><ArticleId IdType="pmc">PMC2725535</ArticleId><ArticleId IdType="pubmed">19515870</ArticleId></ArticleIdList></Reference><Reference><Citation>Palacio N, Dangi T, Chung YR, Wang Y, Loredo-Varela JL, Zhang Z, et al. . Early type I IFN blockade improves the efficacy of viral vaccines. J Exp Med (2020) 217(12):e20191220. doi: 10.1084/jem.20191220</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20191220</ArticleId><ArticleId IdType="pmc">PMC7953731</ArticleId><ArticleId IdType="pubmed">32820330</ArticleId></ArticleIdList></Reference><Reference><Citation>Alter G, Yu J, Liu J, Chandrashekar A, Borducchi EN, Tostanoski LH, et al. . Immunogenicity of Ad26. COV2.S Vaccine against SARS-CoV-2 variants humans. Nat (2021) 596(7871):268&#x2013;72. doi: 10.1038/s41586-021-03681-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03681-2</ArticleId><ArticleId IdType="pmc">PMC8357629</ArticleId><ArticleId IdType="pubmed">34107529</ArticleId></ArticleIdList></Reference><Reference><Citation>Roederer M, Nozzi JL, Nason MC. SPICE: exploration and analysis of post-cytometric complex multivariate datasets. Cytometry A (2011) 79:167&#x2013;74. doi: 10.1002/cyto.a.21015</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cyto.a.21015</ArticleId><ArticleId IdType="pmc">PMC3072288</ArticleId><ArticleId IdType="pubmed">21265010</ArticleId></ArticleIdList></Reference><Reference><Citation>Gold L, Ayers D, Bertino J, Bock C, Bock A, Brody EN, et al. . Aptamer-based multiplexed proteomic technology for biomarker discovery. PloS One (2010) 5:e15004. doi: 10.1371/journal.pone.0015004</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0015004</ArticleId><ArticleId IdType="pmc">PMC3000457</ArticleId><ArticleId IdType="pubmed">21165148</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al. . Attributes and predictors of long COVID. Nat Med (2021) 27:626&#x2013;31. doi: 10.1038/s41591-021-01292-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang E, Ekundayo O, Peipert JD, Edwards N, Bansal A, Richardson C, et al. . Validation of the patient-reported outcomes measurement information system (PROMIS)-57 and -29 item short forms among kidney transplant recipients. Qual Life Res (2019) 28:815&#x2013;27. doi: 10.1007/s11136-018-2058-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-018-2058-2</ArticleId><ArticleId IdType="pubmed">30467780</ArticleId></ArticleIdList></Reference><Reference><Citation>Grifoni A, Weiskopf D, Ramirez SI, Mateus J, Dan JM, Moderbacher CR, et al. . Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell (2020) 181:1489&#x2013;1501 e15. doi: 10.1016/j.cell.2020.05.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.05.015</ArticleId><ArticleId IdType="pmc">PMC7237901</ArticleId><ArticleId IdType="pubmed">32473127</ArticleId></ArticleIdList></Reference><Reference><Citation>Chansaenroj J, Yorsaeng R, Posuwan N, Puenpa J, Wanlapakorn N, Sudhinaraset N, et al. . Long-term specific IgG response to SARS-CoV-2 nucleocapsid protein in recovered COVID-19 patients. Sci Rep (2021) 11:23216. doi: 10.1038/s41598-021-02659-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-02659-4</ArticleId><ArticleId IdType="pmc">PMC8636620</ArticleId><ArticleId IdType="pubmed">34853374</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H, Hou J, Jiang X, Ma S, Meng M, Wang B, et al. . Response of memory CD8+ T cells to severe acute respiratory syndrome (SARS) coronavirus in recovered SARS patients and healthy individuals. J Immunol (2005) 175:591&#x2013;8. doi: 10.4049/jimmunol.175.1.591</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.175.1.591</ArticleId><ArticleId IdType="pubmed">15972696</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiao Z, Pan X, Parlayan C, Ojima H, Kondo T. Proteomic study of hepatocellular carcinoma using a novel modified aptamer-based array (SOMAscan) platform. Biochim Biophys Acta Proteins Proteom (2017) 1865:434&#x2013;43. doi: 10.1016/j.bbapap.2016.09.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbapap.2016.09.011</ArticleId><ArticleId IdType="pubmed">27663888</ArticleId></ArticleIdList></Reference><Reference><Citation>Timsina J, Gomez-Fonseca D, Wang L, Do A, Western D, Alvarez I, et al. . Comparative analysis of alzheimer's disease cerebrospinal fluid biomarkers measurement by multiplex SOMAscan platform and immunoassay-based approach. J Alzheimers Dis (2022) 89:193&#x2013;207. doi: 10.3233/JAD-220399</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-220399</ArticleId><ArticleId IdType="pmc">PMC9562128</ArticleId><ArticleId IdType="pubmed">35871346</ArticleId></ArticleIdList></Reference><Reference><Citation>George MJ, Kleveland O, Garcia-Hernandez J, Palmen J, Lovering R, Wiseth R, et al. . Novel insights into the effects of interleukin 6 antagonism in non-ST-Segment-Elevation myocardial infarction employing the SOMAscan proteomics platform. J Am Heart Assoc (2020) 9:e015628. doi: 10.1161/JAHA.119.015628</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.119.015628</ArticleId><ArticleId IdType="pmc">PMC7429051</ArticleId><ArticleId IdType="pubmed">32515246</ArticleId></ArticleIdList></Reference><Reference><Citation>Parolo S, Marchetti L, Lauria M, Misselbeck K, Scott-Boyer MP, Caberlotto L, et al. . Combined use of protein biomarkers and network analysis unveils deregulated regulatory circuits in duchenne muscular dystrophy. PloS One (2018) 13:e0194225. doi: 10.1371/journal.pone.0194225</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0194225</ArticleId><ArticleId IdType="pmc">PMC5846794</ArticleId><ArticleId IdType="pubmed">29529088</ArticleId></ArticleIdList></Reference><Reference><Citation>Uchida Y, Kawai K, Ibusuki A, Kanekura T. Role for e-cadherin as an inhibitory receptor on epidermal gammadelta T cells. J Immunol (2011) 186:6945&#x2013;54. doi: 10.4049/jimmunol.1003853</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1003853</ArticleId><ArticleId IdType="pubmed">21562159</ArticleId></ArticleIdList></Reference><Reference><Citation>Matkovic R, Morel M, Lanciano S, Larrous P, Martin B, Bejjani F, et al. . TASOR epigenetic repressor cooperates with a CNOT1 RNA degradation pathway to repress HIV. Nat Commun (2022) 13:66. doi: 10.1038/s41467-021-27650-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-27650-5</ArticleId><ArticleId IdType="pmc">PMC8748822</ArticleId><ArticleId IdType="pubmed">35013187</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiskopf D, Schmitz KS, Raadsen MP, Grifoni A, Okba NMA, Endeman H, et al. . Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome. Sci Immunol (2020) 5(48):eabd2071. doi: 10.1126/sciimmunol.abd2071</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abd2071</ArticleId><ArticleId IdType="pmc">PMC7319493</ArticleId><ArticleId IdType="pubmed">32591408</ArticleId></ArticleIdList></Reference><Reference><Citation>Sekine T, Perez-Potti A, Rivera-Ballesteros O, Stralin K, Gorin JB, Olsson A, et al. . Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19. Cell (2020) 183:158&#x2013;168 e14. doi: 10.1016/j.cell.2020.08.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.08.017</ArticleId><ArticleId IdType="pmc">PMC7427556</ArticleId><ArticleId IdType="pubmed">32979941</ArticleId></ArticleIdList></Reference><Reference><Citation>Klingenstein M, Klingenstein S, Neckel PH, Mack AF, Wagner AP, Kleger A, et al. . Evidence of SARS-CoV2 entry protein ACE2 in the human nose and olfactory bulb. Cells Tissues Organs (2020) 209:155&#x2013;64. doi: 10.1159/000513040</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000513040</ArticleId><ArticleId IdType="pmc">PMC7900466</ArticleId><ArticleId IdType="pubmed">33486479</ArticleId></ArticleIdList></Reference><Reference><Citation>Dangi T, Class J, Palacio N, Richner JM, Penaloza MacMaster P. Combining spike- and nucleocapsid-based vaccines improves distal control of SARS-CoV-2. Cell Rep (2021) 36:109664. doi: 10.1016/j.celrep.2021.109664</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.109664</ArticleId><ArticleId IdType="pmc">PMC8367759</ArticleId><ArticleId IdType="pubmed">34450033</ArticleId></ArticleIdList></Reference><Reference><Citation>Kantonen J, Mahzabin S, Mayranpaa MI, Tynninen O, Paetau A, Andersson N, et al. . Neuropathologic features of four autopsied COVID-19 patients. Brain Pathol (2020) 30:1012&#x2013;6. doi: 10.1111/bpa.12889</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12889</ArticleId><ArticleId IdType="pmc">PMC7436498</ArticleId><ArticleId IdType="pubmed">32762083</ArticleId></ArticleIdList></Reference><Reference><Citation>Heming M, Li X, Rauber S, Mausberg AK, Borsch AL, Hartlehnert M, et al. . Neurological manifestations of COVID-19 feature T cell exhaustion and dedifferentiated monocytes in cerebrospinal fluid. Immunity (2021) 54:164&#x2013;175 e6. doi: 10.1016/j.immuni.2020.12.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2020.12.011</ArticleId><ArticleId IdType="pmc">PMC7831653</ArticleId><ArticleId IdType="pubmed">33382973</ArticleId></ArticleIdList></Reference><Reference><Citation>Schweitzer F, Goereci Y, Franke C, Silling S, Bosl F, Maier F, et al. . Cerebrospinal fluid analysis post-COVID-19 is not suggestive of persistent central nervous system infection. Ann Neurol (2022) 91:150&#x2013;7. doi: 10.1002/ana.26262</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26262</ArticleId><ArticleId IdType="pmc">PMC8653324</ArticleId><ArticleId IdType="pubmed">34724243</ArticleId></ArticleIdList></Reference><Reference><Citation>Maccio U, Zinkernagel AS, Schuepbach R, Probst-Mueller E, Frontzek K, Brugger SD, et al. . Long-term persisting SARS-CoV-2 RNA and pathological findings: lessons learnt from a series of 35 COVID-19 autopsies. Front Med (Lausanne) (2022) 9:778489. doi: 10.3389/fmed.2022.778489</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.778489</ArticleId><ArticleId IdType="pmc">PMC8865372</ArticleId><ArticleId IdType="pubmed">35223894</ArticleId></ArticleIdList></Reference><Reference><Citation>Visvabharathy L, Orban ZS, Koralnik IJ. Case report: treatment of long COVID with a SARS-CoV-2 antiviral and IL-6 blockade in a patient with rheumatoid arthritis and SARS-CoV-2 antigen persistence. Front Med (Lausanne) (2022) 9:1003103. doi: 10.3389/fmed.2022.1003103</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.1003103</ArticleId><ArticleId IdType="pmc">PMC9537824</ArticleId><ArticleId IdType="pubmed">36213654</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Elslande J, Oyaert M, Ailliet S, Van Ranst M, Lorent N, Vande Weygaerde Y, et al. . Longitudinal follow-up of IgG anti-nucleocapsid antibodies in SARS-CoV-2 infected patients up to eight months after infection. J Clin Virol (2021) 136:104765. doi: 10.1016/j.jcv.2021.104765</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2021.104765</ArticleId><ArticleId IdType="pmc">PMC7891078</ArticleId><ArticleId IdType="pubmed">33636554</ArticleId></ArticleIdList></Reference><Reference><Citation>Abreu CM, Veenhuis RT, Shirk EN, Queen SE, Bullock BT, Mankowski JL, et al. . Quantitative viral outgrowth assay to measure the functional SIV reservoir in myeloid cells. Methods Mol Biol (2022) 2407:333&#x2013;56. doi: 10.1007/978-1-0716-1871-4_22</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-0716-1871-4_22</ArticleId><ArticleId IdType="pubmed">34985674</ArticleId></ArticleIdList></Reference><Reference><Citation>
Singh U GL. Selective trial of paxlovid for PASC (STOP-PASC): randomized double-blind placebo-controlled pilot trial of paxlovid for the treatment of PASC, ClinicalTrials.gov. (2022). Available at: https://clinicaltrials.gov/ct2/show/NCT05576662.</Citation></Reference><Reference><Citation>Elyanow R, Snyder TM, Dalai SC, Gittelman RM, Boonyaratanakornkit J, Wald A, et al. . T Cell receptor sequencing identifies prior SARS-CoV-2 infection and correlates with neutralizing antibodies and disease severity. JCI Insight (2022) 7(10):e150070. doi: 10.1172/jci.insight.150070</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.150070</ArticleId><ArticleId IdType="pmc">PMC9220924</ArticleId><ArticleId IdType="pubmed">35439166</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng Y, Felce SL, Dong D, Penkava F, Mentzer AJ, Yao X, et al. . An immunodominant NP105-113-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease. Nat Immunol (2022) 23:50&#x2013;61. doi: 10.1038/s41590-021-01084-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01084-z</ArticleId><ArticleId IdType="pmc">PMC8709787</ArticleId><ArticleId IdType="pubmed">34853448</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan JT, Whitmire JK, Ahmed R, Pearson TC, Larsen CP. 4-1BB ligand, a member of the TNF family, is important for the generation of antiviral CD8 T cell responses. J Immunol (1999) 163:4859&#x2013;68. doi: 10.4049/jimmunol.163.9.4859</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.163.9.4859</ArticleId><ArticleId IdType="pubmed">10528187</ArticleId></ArticleIdList></Reference><Reference><Citation>Derhovanessian E, Maier AB, Hahnel K, Beck R, de Craen AJM, Slagboom EP, et al. . Infection with cytomegalovirus but not herpes simplex virus induces the accumulation of late-differentiated CD4+ and CD8+ T-cells in humans. J Gen Virol (2011) 92:2746&#x2013;56. doi: 10.1099/vir.0.036004-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.036004-0</ArticleId><ArticleId IdType="pubmed">21813708</ArticleId></ArticleIdList></Reference><Reference><Citation>Diehl S, Anguita J, Hoffmeyer A, Zapton T, Ihle JN, Fikrig E, et al. . Inhibition of Th1 differentiation by IL-6 is mediated by SOCS1. Immunity (2000) 13:805&#x2013;15. doi: 10.1016/S1074-7613(00)00078-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1074-7613(00)00078-9</ArticleId><ArticleId IdType="pubmed">11163196</ArticleId></ArticleIdList></Reference><Reference><Citation>Channappanavar R, Perlman S. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Semin Immunopathol (2017) 39:529&#x2013;39. doi: 10.1007/s00281-017-0629-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00281-017-0629-x</ArticleId><ArticleId IdType="pmc">PMC7079893</ArticleId><ArticleId IdType="pubmed">28466096</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu W, Dietze KK, Gibbert K, Lang KS, Trilling M, Yan H, et al. . TLR ligand induced IL-6 counter-regulates the anti-viral CD8(+) T cell response during an acute retrovirus infection. Sci Rep (2015) 5:10501. doi: 10.1038/srep10501</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep10501</ArticleId><ArticleId IdType="pmc">PMC4440206</ArticleId><ArticleId IdType="pubmed">25994622</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin H, Blackburn SD, Blattman JN, Wherry EJ. Viral antigen and extensive division maintain virus-specific CD8 T cells during chronic infection. J Exp Med (2007) 204:941&#x2013;9. doi: 10.1084/jem.20061937</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20061937</ArticleId><ArticleId IdType="pmc">PMC2118542</ArticleId><ArticleId IdType="pubmed">17420267</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnstorf I, Borsa M, Baumann N, Pallmer K, Yermanos A, Joller N, et al. . Chronic virus infection compromises memory bystander T cell function in an IL-6/STAT1-dependent manner. J Exp Med (2019) 216:571&#x2013;86. doi: 10.1084/jem.20181589</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20181589</ArticleId><ArticleId IdType="pmc">PMC6400541</ArticleId><ArticleId IdType="pubmed">30745322</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultheiss C, Willscher E, Paschold L, Gottschick C, Klee B, Henkes SS, et al. . IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19. Cell Rep Med (2022) 3:100663. doi: 10.1016/j.xcrm.2022.100663</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2022.100663</ArticleId><ArticleId IdType="pmc">PMC9214726</ArticleId><ArticleId IdType="pubmed">35732153</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen SF, Ham B, Haichin M, Walters IC, Tohyama S, Sotocinal SG, et al. . Increased pain sensitivity and decreased opioid analgesia in T-cell-deficient mice and implications for sex differences. Pain (2019) 160:358&#x2013;66. doi: 10.1097/j.pain.0000000000001420</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000001420</ArticleId><ArticleId IdType="pubmed">30335680</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang T, Ji YL, Yang YY, Xiong XY, Wang IM, Sandford AJ, et al. . Transcriptomic profiling of peripheral blood CD4(+) T-cells in asthmatics with and without depression. Gene (2015) 565:282&#x2013;7. doi: 10.1016/j.gene.2015.04.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2015.04.029</ArticleId><ArticleId IdType="pubmed">25871513</ArticleId></ArticleIdList></Reference><Reference><Citation>Pallmer K, Barnstorf I, Baumann NS, Borsa M, Jonjic S, Oxenius A. NK cells negatively regulate CD8 T cells via natural cytotoxicity receptor (NCR) 1 during LCMV infection. PloS Pathog (2019) 15:e1007725. doi: 10.1371/journal.ppat.1007725</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1007725</ArticleId><ArticleId IdType="pmc">PMC6469806</ArticleId><ArticleId IdType="pubmed">30995287</ArticleId></ArticleIdList></Reference><Reference><Citation>Correale J, Villa A. Isolation and characterization of CD8+ regulatory T cells in multiple sclerosis. J Neuroimmunol (2008) 195:121&#x2013;34. doi: 10.1016/j.jneuroim.2007.12.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2007.12.004</ArticleId><ArticleId IdType="pubmed">18234356</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho JH, Kim HO, Webster K, Palendira M, Hahm B, Kim KS, et al. . Calcineurin-dependent negative regulation of CD94/NKG2A expression on naive CD8+ T cells. Blood (2011) 118:116&#x2013;28. doi: 10.1182/blood-2010-11-317396</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2010-11-317396</ArticleId><ArticleId IdType="pubmed">21540458</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng M, Gao Y, Wang G, Song G, Liu S, Sun D, et al. . Functional exhaustion of antiviral lymphocytes in COVID-19 patients. Cell Mol Immunol (2020) 17:533&#x2013;5. doi: 10.1038/s41423-020-0402-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-020-0402-2</ArticleId><ArticleId IdType="pmc">PMC7091858</ArticleId><ArticleId IdType="pubmed">32203188</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>